Cargando…

Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?

Detalles Bibliográficos
Autores principales: Buskermolen, Maaike, te Paske, Karlijn, van Beek, Janko, Kortbeek, Titia, Götz, Hannelore, Fanoy, Ewout, Feenstra, Sabiena, Richardus, Jan Hendrik, Vollaard, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236092/
https://www.ncbi.nlm.nih.gov/pubmed/34147529
http://dx.doi.org/10.1016/j.jinf.2021.06.015
_version_ 1783714466372780032
author Buskermolen, Maaike
te Paske, Karlijn
van Beek, Janko
Kortbeek, Titia
Götz, Hannelore
Fanoy, Ewout
Feenstra, Sabiena
Richardus, Jan Hendrik
Vollaard, Albert
author_facet Buskermolen, Maaike
te Paske, Karlijn
van Beek, Janko
Kortbeek, Titia
Götz, Hannelore
Fanoy, Ewout
Feenstra, Sabiena
Richardus, Jan Hendrik
Vollaard, Albert
author_sort Buskermolen, Maaike
collection PubMed
description
format Online
Article
Text
id pubmed-8236092
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82360922021-06-28 Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound? Buskermolen, Maaike te Paske, Karlijn van Beek, Janko Kortbeek, Titia Götz, Hannelore Fanoy, Ewout Feenstra, Sabiena Richardus, Jan Hendrik Vollaard, Albert J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-08 2021-06-18 /pmc/articles/PMC8236092/ /pubmed/34147529 http://dx.doi.org/10.1016/j.jinf.2021.06.015 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Buskermolen, Maaike
te Paske, Karlijn
van Beek, Janko
Kortbeek, Titia
Götz, Hannelore
Fanoy, Ewout
Feenstra, Sabiena
Richardus, Jan Hendrik
Vollaard, Albert
Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title_full Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title_fullStr Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title_full_unstemmed Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title_short Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound?
title_sort relapse in the first 8 weeks after onset of covid-19 disease in outpatients: viral reactivation or inflammatory rebound?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236092/
https://www.ncbi.nlm.nih.gov/pubmed/34147529
http://dx.doi.org/10.1016/j.jinf.2021.06.015
work_keys_str_mv AT buskermolenmaaike relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT tepaskekarlijn relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT vanbeekjanko relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT kortbeektitia relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT gotzhannelore relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT fanoyewout relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT feenstrasabiena relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT richardusjanhendrik relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound
AT vollaardalbert relapseinthefirst8weeksafteronsetofcovid19diseaseinoutpatientsviralreactivationorinflammatoryrebound